Dropped-Head syndrome: a possible new variant of clozapine-induced inflammation during titration
- PMID: 39611715
- DOI: 10.1097/YIC.0000000000000507
Dropped-Head syndrome: a possible new variant of clozapine-induced inflammation during titration
References
-
- Aronson JK, Ferner RE (2005). ‘Clarification of terminology in drug safety’. Drug Saf 28:851–870.
-
- Bachmann CJ, Aagaard L, Bernardo M, Brandt L, Cartabia M, Clavenna A, et al. (2017). ‘International trends in clozapine use: a study in 17 countries’. Acta Psychiatr Scand 136:37–51.
-
- Béchard L, Corbeil O, Thivierge M-A, Assaad I, Boulanger C, Mailhot M-P, et al. (2022). ‘Management of Rhabdomyolysis in a Patient Treated with Clozapine: A Case Report and Clinical Recommendations’. Clin Psychopharmacol Neurosci 20:194–198.
-
- Bellissima BL, Tingle MD, Cicović A, Alawami M, Kenedi C (2018). ‘A systematic review of clozapine-induced myocarditis’. Int J Cardiol 259:122–129.
-
- Bertilsson L, Carrillo J, Dahl M, Llerena A, Alm C, Bondesson U, et al. (1994). ‘Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test’. Br J Clin Pharmacol 38:471–473.
Grants and funding
- CIBER/CIBER -Consorcio Centro de Investigación Biomédica en Red
- ISCIII PI20/01555/Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea â€" European Regional Development Fund
- B2017/BMD-3740 AGES-CM 2CM/Madrid Regional Government
- Y2018/TCS-4705 PRACTICO-CM/Madrid Regional Government
LinkOut - more resources
Full Text Sources